Protein Engineering, Vol. 15, No. 12, 1015-1020,
December 2002
© 2002 Oxford University Press
Exploring the potential of the monobody scaffold: effects of loop elongation on the stability of a fibronectin type III domain
1 Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642 and 2 Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA
The tenth fibronectin type III domain of human fibronectin (FNfn10) is a small, monomeric ß-sandwich protein, similar to the immunoglobulins. We have developed small antibody mimics, ‘monobodies’, using FNfn10 as a scaffold. We initially altered two loops of FNfn10 that are structurally equivalent to two of the hypervariable loops of the immunoglobulin domain. In order to assess the possibility of utilizing other loops in FNfn10 for target binding, we determined the effects of the elongation of each loop on the conformational stability of FNfn10. We found that all six loops of FNfn10 allowed the introduction of four glycine residues while retaining the global fold. Insertions in the AB and FG loops exhibited very small degrees of destabilization, comparable to or less than predicted entropic penalties due to the elongation, suggesting the absence of stabilizing interactions in these loops in wild-type FNfn10. Insertions in the BC, CD and DE loops, respectively, resulted in modest destabilization. In contrast, the EF loop elongation was highly destabilizing, consistent with previous studies showing the presence of stabilizing interactions in this loop. These results suggest that all loops, except for the EF loop, can be used for engineering a binding site, thus demonstrating excellent properties of the monobody scaffold.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. B. Boschek, D. O. Apiyo, T. A. Soares, H. E. Engelmann, N. B. Pefaur, T. P. Straatsma, and C. L. Baird Engineering an ultra-stable affinity reagent based on Top7 Protein Eng. Des. Sel., May 1, 2009; 22(5): 325 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Clark, P. A. Boriack-Sjodin, E. Day, J. Eldredge, C. Fitch, M. Jarpe, S. Miller, Y. Li, K. Simon, and H. W.T. van Vlijmen An antibody loop replacement design feasibility study and a loop-swapped dimer structure Protein Eng. Des. Sel., February 1, 2009; 22(2): 93 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J Kojetin, T. P Burris, E. V Jensen, and S. A Khan Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor Endocr. Relat. Cancer, December 1, 2008; 15(4): 851 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Hu, H. Wang, H. Ke, and B. Kuhlman High-resolution design of a protein loop PNAS, November 6, 2007; 104(45): 17668 - 17673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Juraja, T. D. Mulhern, P. J. Hudson, M. K. Hattarki, J. A. Carmichael, and S. D. Nuttall Engineering of the Escherichia coli Im7 immunity protein as a loop display scaffold Protein Eng. Des. Sel., May 1, 2006; 19(5): 231 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.H. Parker, Y. Chen, F. Danehy, K. Dufu, J. Ekstrom, E. Getmanova, J. Gokemeijer, L. Xu, and D. Lipovsek Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor two Protein Eng. Des. Sel., September 1, 2005; 18(9): 435 - 444. [Abstract] [Full Text] [PDF]
|
|